A researcher at the center of questions about a biotech’s controversial experimental treatment for Alzheimer’s disease has lost five papers in PLOS One.  The journal says it is retracting the articles, by Hoau-Yan Wang and colleagues, over concerns about the integrity of the data and the images in the papers. Wang does not agree with … Continue reading Five studies linked to Cassava Sciences retracted